Although recurrence and mortality rates were numerically higher after 12 months of follow-up in patients with CK7- and CK19-negative HCC compared to those with DPHCC, DFS and OS were numerically lower in patients with DPHCC. The gene discussed is KRT19; the disease is hepatocellular carcinoma.